Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Gunn

Critical Care Medicine Charleston, SC Medical Doctor

NPI 1386760080 CMS profile 289214

125 Doughty St Ste 200, Unit B, Charleston, SC 29403

Open in the dashboard

General payments

$864

51 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$215,684 paid to institutions, not to them · program year 2019

Through program year 2025, Jason Gunn of Charleston, SC is reported in the CMS Open Payments database as having received $864 across 51 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $215,684 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 62nd percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $173 9
2024 General $214 8
2023 General $123 5
2022 General $146 11
2021 General $137 13
2020 General $38 3
2019 General $33 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Gunn
  • Critical Care Medicine median
  • Middle half of Critical Care Medicine
  • National median

In program year 2025, general payments to Jason Gunn were reported at $173. Among 2,664 Critical Care Medicine profiles paid that year, the median was $189 and the middle half received between $59 and $844.

Show as a table
Year Jason Gunn Critical Care Medicine median Middle half National median
2019 $33 $149 $51–$535 $163
2020 $38 $110 $30–$325 $114
2021 $137 $125 $34–$403 $132
2022 $146 $157 $49–$582 $149
2023 $123 $162 $56–$621 $160
2024 $214 $168 $53–$634 $164
2025 $173 $189 $59–$844 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Electromed, Inc. $174 17 payments
  2. Axsome Therapeutics, Inc. $171 6 payments
  3. GlaxoSmithKline, LLC. $101 6 payments
  4. Inspire Medical Systems, Inc. $80 2 payments
  5. Harmony Biosciences LLC $79 3 payments
  6. Genentech USA, Inc. $45 3 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $32 1 payment
  8. Jazz Pharmaceuticals Inc. $22 1 payment
  9. Inogen, Inc. $21 3 payments
  10. Intuitive Surgical, Inc. $20 1 payment
  11. Other $118 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $864 51 payments
Products named General payments · program years 2019–2025
  1. Sunosi $171 6 payments
  2. SMARTVEST Hfcwo $116 12 payments
  3. NUCALA $82 5 payments
  4. INSPIRE $80 2 payments
  5. SMARTVEST Hfcwo $58 5 payments
  6. Xolair $45 3 payments
  7. WAKIX Narcoplepsy $34 1 payment
  8. HYQVIA $32 1 payment
  9. WAKIX Sleep Medicine $30 1 payment
  10. Esbriet $30 2 payments
  11. Other $229 16 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 31 drugs

Part D claims

1,067

Median for Internal Medicine: 777

Drug cost

$895,288

Median for Internal Medicine: $73,373

Branded share of claims

70.1%

Median for Internal Medicine: 19.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xywav Sodium,calcium,mag,pot Oxybate Brand 15 $294,544
Xolair Omalizumab Brand 39 $197,571
Opsumit Macitentan Brand 11 $138,433
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 93 $95,767
Spiriva Respimat Tiotropium Bromide Brand 46 $30,545
Sunosi Solriamfetol Hcl Brand 17 $28,040
Breo Ellipta Fluticasone/Vilanterol Brand 19 $18,664
Anoro Ellipta Umeclidinium Brm/Vilanterol Tr Brand 22 $14,915
Fluticasone-Salmeterol Fluticasone Propion/Salmeterol Brand 72 $11,943
Breztri Aerosphere Budesonide/Glycopyr/Formoterol Brand 17 $10,601

The 10 drugs with the highest cost, of 31 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$165,682

Medicare's payments for the services billed

Medicare patients

1,211

Average age 74

Services billed

2,695

629 women, 582 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Diabetes 38%
Ischemic heart disease 37%
Atrial fibrillation 30%
Chronic kidney disease 30%
Depression 30%
Heart failure 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Sunosi
  • Axsome Therapeutics, Inc. $111
$111 17 —
WAKIX
  • Harmony Biosciences LLC $34
$34 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

51 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Critical Care Medicine in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record